Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence

This publication has 38 references indexed in Scilit:

• Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers
  Clinical Therapeutics, 2007
• A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers
  Clinical Therapeutics, 2007
• Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: A randomized controlled trial.
  Psychology of Addictive Behaviors, 2007
• Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo‐controlled trial
  Addiction, 2004
• A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees
  Nicotine & Tobacco Research, 2004
• Measures of abstinence in clinical trials: issues and recommendations
  Nicotine & Tobacco Research, 2003
• Biochemical verification of tobacco use and cessation
  Nicotine & Tobacco Research, 2002
• Reliability and validity of a smoking timeline follow-back interview.
  Psychology of Addictive Behaviors, 1998
• Programmed therapeutic messages as a smoking treatment adjunct: Reducing the impact of negative affect.
  Health Psychology, 1995
• Placebo controlled trial of nicotine chewing gum in general practice.
  BMJ, 1984